Tate & Lyle plc (LON:TATE - Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 581.76 ($7.98) and traded as low as GBX 512 ($7.03). Tate & Lyle shares last traded at GBX 519.50 ($7.13), with a volume of 872,884 shares trading hands.
Tate & Lyle Trading Up 1.4%
The company has a debt-to-equity ratio of 47.66, a quick ratio of 1.77 and a current ratio of 3.22. The company has a market capitalization of £2.30 billion, a PE ratio of 11.00, a PEG ratio of 1.37 and a beta of 0.50. The stock has a fifty day moving average of GBX 554.79 and a 200 day moving average of GBX 579.65.
Tate & Lyle (LON:TATE - Get Free Report) last released its earnings results on Thursday, May 22nd. The company reported GBX 50.30 ($0.69) EPS for the quarter. Tate & Lyle had a net margin of 11.41% and a return on equity of 15.37%. As a group, sell-side analysts predict that Tate & Lyle plc will post 51.3392857 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Tate & Lyle news, insider Nick Hampton bought 3,321 shares of Tate & Lyle stock in a transaction dated Thursday, May 22nd. The shares were purchased at an average cost of GBX 542 ($7.44) per share, for a total transaction of £17,999.82 ($24,701.28). Also, insider Sarah Kuijlaars purchased 15,000 shares of the stock in a transaction that occurred on Wednesday, May 28th. The stock was acquired at an average cost of GBX 562 ($7.71) per share, with a total value of £84,300 ($115,685.47). 2.22% of the stock is owned by company insiders.
Tate & Lyle Company Profile
(
Get Free Report)
Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products.
Featured Stories
Before you consider Tate & Lyle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tate & Lyle wasn't on the list.
While Tate & Lyle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.